BIO-RAD LAB-A
BIO-RAD LAB-A operates in Diversified Metals & Mining.
BIO-RAD LAB-A (BUWA) - Total Assets
Latest total assets as of September 2024: €10.60 Billion EUR
Based on the latest financial reports, BIO-RAD LAB-A (BUWA) holds total assets worth €10.60 Billion EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BIO-RAD LAB-A - Total Assets Trend (2016–2023)
This chart illustrates how BIO-RAD LAB-A’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BIO-RAD LAB-A - Asset Composition Analysis
Current Asset Composition (December 2023)
BIO-RAD LAB-A's total assets of €10.60 Billion consist of 24.8% current assets and 75.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.3% |
| Accounts Receivable | €489.02 Million | 4.0% |
| Inventory | €780.52 Million | 6.4% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €320.50 Million | 2.6% |
| Goodwill | €413.60 Million | 3.4% |
Asset Composition Trend (2016–2023)
This chart illustrates how BIO-RAD LAB-A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BIO-RAD LAB-A's current assets represent 24.8% of total assets in 2023, a decrease from 47.9% in 2016.
- Cash Position: Cash and equivalents constituted 3.3% of total assets in 2023, down from 11.9% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, a decrease from 16.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 6.4% of total assets.
BIO-RAD LAB-A Competitors by Total Assets
Key competitors of BIO-RAD LAB-A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €15.07 Billion |
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN
|
Germany | €7.86 Billion |
|
PRICELINE.COM
BE:PCE1
|
Germany | €27.98 Billion |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1
|
Germany | €27.98 Billion |
|
MURPHY USA
BE:1MU
|
Germany | €4.40 Billion |
|
RESMED (RME.SG)
STU:RME
|
Germany | €7.22 Billion |
|
DIOS EXPLORATIONS
BE:BFM
|
Germany | €7.25 Million |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
Germany | €25.76 Billion |
BIO-RAD LAB-A - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - BIO-RAD LAB-A generates 0.22x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BIO-RAD LAB-A is currently not profitable relative to its asset base.
BIO-RAD LAB-A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.14 | 5.64 | 2.41 |
| Quick Ratio | 4.52 | 4.25 | 1.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €2.56 Billion | € 2.59 Billion | € 1.27 Billion |
BIO-RAD LAB-A - Advanced Valuation Insights
This section examines the relationship between BIO-RAD LAB-A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -8.9% |
| Total Assets | €12.30 Billion |
| Market Capitalization | $2.58 Million USD |
Valuation Analysis
Below Book Valuation: The market values BIO-RAD LAB-A's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BIO-RAD LAB-A's assets decreased by 8.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BIO-RAD LAB-A (2016–2023)
The table below shows the annual total assets of BIO-RAD LAB-A from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €12.30 Billion | -8.91% |
| 2022-12-31 | €13.50 Billion | -24.15% |
| 2021-12-31 | €17.80 Billion | +37.21% |
| 2020-12-31 | €12.97 Billion | +61.98% |
| 2019-12-31 | €8.01 Billion | +42.73% |
| 2018-12-31 | €5.61 Billion | +31.31% |
| 2017-12-31 | €4.27 Billion | +10.97% |
| 2016-12-31 | €3.85 Billion | -- |